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Most of the deaths during the pandemic of influenza in 1918-19 were probably 
due to secondary bacterial pneumonia superimposed on a primary viral infection 
of the lung (3-5).  Recent progress in the chemotherapy of bacterial pneumonia 
(6--8) has been sufficiently encouraging to suggest that such treatment may be 
effective  in  controlling  secondary  pneumonia  in  influenza  pandemics.  The 
present investigations have concerned the study of sulfonamide chemotherapy in 
combined viral and bacterial infections produced experimentally in laboratory 
animals  under  carefully controlled conditions.  The  results  of  these  experi- 
ments indicate that the sulfonamide drugs act as effective antibacterial agents 
even in the presence of active infection with influenza virus. 
Methods  and  Materials 
Virus.--The PR8  t and Weiss  2 strains of Type A influenza  virus and the Lee  2 strain of 
Type B influenza virus were passed through mice and suspensions of infected mouse lung were 
stored in a cabinet containing solid carbon dioxide. 
In the preparation of virus for inoculation of rats, infected mouse lungs were ground with- 
out abrasive and a 10 per cent suspension was prepared as described in previous experiments 
with rats (9). 
For inoculation of mice, infected mouse lungs were ground with fine sterile sand, 10 per cent 
suspensions were prepared with broth,  "~ and aerobic cultures were made on blood agar plates. 
Such suspensions were stored in the cabinet containing solid carbon dioxide until the results of 
cultures were obtained.  All batches containing bacteria were discarded and the uncontam- 
inated lots were thawed and subjected to horizontal centrifug~tion.  The supematant fluid of 
each batch was distributed after centrifugation in 0.2 mh amounts and stored again in the 
cabinet containing solid carbon dioxide.  Portions of the same batch were  used both for 
determining the sublethal dilution and for the final experiment.  At the time of use, a single 
tube was thawed and serial tenfold dilutions in broth were made using a separate pipette for 
each dilution. 
* This investigation was aided in part by the Commission on Influenza, Board for the In- 
vestigation and Control of Influenza and Other Epidemic Diseases in the Army, Preventive 
Medicine Service, Office  of the Surgeon General, United States Army. 
Preliminary reports have been made on two phases of this investigation (1, 2). 
x Kindly supplied by Dr. S. E. Sulkin. 
s Kindly supplied by Dr. Thomas Francis, Jr. 
"~ Tryptose or tryptose phosphate broth (Difco). 
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Baaeria.--Two strains of bacteria virulent for mice were used--the A5 strain of Type I 
pneumococcus (I0, 11), and the C203 strain of group A hemolytic streptococcus.  4  The cul- 
tures Were passed frequently through mice by intraabdominal inoculation in order to maintain 
virulence.  Preservation of the bacteria was accomplished by keeping cultures in defibrinated 
rabbit blood in the refrigerator or the cabinet containing solid carbon'  dioxide. 
In preparation for intrabronchial inoculation, the bacteria were allowed to grow for 6 to 12 
hours in horse or beef infusion broth containing rabbit blood, and from the resulting culture 
serial tenfold dilutions in tryptose or tryptose phosphate broth were prepared.  One of these 
dilutions was used for inoculation and two pour plates were made from 1 ml. each of the dilu- 
tion 10  -s in order to calculate the number of bacteria in the inoculum. 
For administration by inhalation of fine droplets, the bacteria were allowed to grow for 24 
hours on blood agar slants, and from this growth a heavy suspension of bacteria in physiologi- 
cal salt solution was prepared. 
Animals.--Adult white rats weighing 150 to 200 gin. were used in all experiments. 
Swiss mice were of a single strain and obtained from the same dealer?  The ages of the mice 
varied from about 3 to 6 weeks. 
Intrabronchial Inoculation of Rats and Mice.--Rats were inoculated intrabronchlally by a 
method already described (12). 
In preliminary experiments with mice intranasal inoculation under light ether anesthesia 
was carried out in the usual manner but inconsistent results were obtained.  Therefore, the 
method of intrabronchial inoculation of rats was modified so that it could be used in mice in 
order to insure the inoculum reaching the lung in every instance. 
For intrabronchial inoculation, the mice were anesthetized by intraabdominal injection of 
0.4 to 0.5 ml. of a 2.5 per cent solution or chloral hydrate in physiological salt solution.  The 
desired depth of anesthesia was regulated by variation in the amount of solution injected in 
different animals.  When complete relaxation of the mouse was obtained the animal was held 
on its back on an inclined board by a  rubber band passed over the upper incisor teeth.  A 
small bulldog clamp was suspended from a  superstructure by a  rubber band and served to 
retract the tongue and keep the mouth open.  The pharynx was then held widely open by the 
tips of a  small Kelly clamp and illumination from a  head mirror was used to visualize the 
larynx~  The cannula employed for inoculation was made by filing off the point of a 20 gauge 
needle and bending the termir/al 0.4 cm. to a  slight angle.  Under direct visualization the 
eannula was passed through the larynx with the tip pointing ventrad.  After it was in the 
trachea, it was gently passed downward with rotation of the tip to the left and dorsad.  Posi- 
tive eviderlce that the cannula was in the trachea was always obtained by attaching it to a 
piece of rubber tubing connected to a small water manometer consisting of a glass tube With 
one end immersed in a flask of water.  Oscillations of the level of water in the tube indicated 
respiratory excursions and it was found that there was a  sharp decrease in their amplitude 
when the cannula entered the left main bronchus.  When the cannula was in the bronchus, a 
tuberculin syringe was attached to it and the cannula removed after injection of the inoculum. 
The total amount of fluid injected was 0.1 ml., and, since the cannula itself held 0.05 ml. of 
fluid, the volume deposited in the bronchus was 0.05 ml.  In order to prevent regurgitation 
after inoculation, the mice were suspended for 20 minutes by hooking the upper incisor teeth 
over rubber bands stretched between nails on a vertical board. 
Determ$nation of Sublethal Dose of Virus for Mice.--In order to determine the amount of 
virus that would produce non-fatal lesions, preliminary titration with tenfold dilutions of a 
given batch of virus was carried outby intrabronchial inoculation of mice and that dilution 
was chosen which allowed survival with gross pulmonary lesions.  Another tube was then 
4 Kindly supplied by Dr. Rebecca Lancefield. 
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thawed and this dilution given to a larger number of mice to determine how near it came to the 
ideal in which all mice would survive for 14 days and yet show pulmonary lesions.  With some 
sUspensions~ further modification of the dilution was made in order to achieve this end more 
Closely.  Table I shows tests of dilutions of batches of virus suspensions later used in the ex- 
periments.  In nearly all animals the gross lesion involved part or all of the left lobe. 
Inhalation of Fine Droplets Containing Baeteria.--Mice were made to inhale fine droplets of 
fluid containing bacteria by the use of a simple modification of apparatus devised by others for 
this purpose (13-15). 
The mice were placed in a 5 gallon Pyrex glass jar containing some shavings and supported 
on its side.  The mouth of the jar was 6 cm. in diameter and was tightly fitted with a rubber 
stopper held in place by a metal clamp attached to the neck of the jar.  The stopper was per- 
forated by two holes for glass tubes to be used for inlet and outlet.  These tubes extended for 
10 to 15 cm. into the jar and had perforations of their sides to prevent obstruction to the flow 
of air by the bodies of the mice. 
The turbid suspension of bacteria was placed in an atomizer  6 (14) in 20 ml. amounts and the 
atomizer connected to a compressed air line.  The pressure was maintained at 500 mm. of 
TABLE  I 
Tests for Sublethal Dose of Influenza  Virus in Mice 
No. of  Strain of virus  Dilution  of  Mice  Mice surviving  Survivors 
experiment  virus  inoculated  14 days  showing  lesions 
1 
2 
3 
4 
5 
6 
7~ 
PR8 
PR8 
PR8 
PR8 
PR8 
Weiss 
Lee 
10-7 
0.5 X  10  -7 
10-7 
10-7 
0.5 X  10  -7 
2 X  10  -7 
10-  4 
8 
13 
8 
12 
15 
10 
11 
6 
8* 
8 
11 
14 
8 
9 
6 
8 
8 
11 
13 
6 
9 
* Killed for observation of lesions on the llth day. 
Done as a part of Experiment 4, Table VII. 
mercury by observation of a  mercury manometer connected by a  side arm.  Between the 
atomizer and the inlet of the jar was a small bottle serving as a trap to catch any large drops of 
fluid coming from the atomizer. 
The outlet of the 5 gallon jar was connected to two bottles in series so that the air containing 
droplets with bacteria would bubble through 0.5 per cent cresol in both bottles.  Over the 
outlet of the second bottle in series several layers of flannel were fled.  A blood agar plate held 
over the flannel during operation of the system showed that this method prevented contami- 
nation of the air of the room with the pathogenic bacteria. 
Sulfonamide  Chemotherapy.--Rats  were given suifapyridine by gastric tube in amounts 
previously fcund to control experimental pneumococcal pneumonia (10).  In the first and 
second experiments administration of the drug was started before inoculation with virus in 
order to minimize the possibility of secondary infection with other organisms before the in- 
jection of pneumococci.  In these experiments, sulfapyfidine was continued in those animals 
in which it was desired to give chemotherapy.  In control rats, sulfapyridine was stopped and 
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lj hours before inoculation with pneumococci each animal was given para-aminobensoic acid  7 
in order to ensure the cessation of sulfonamide activity. 
Mice were given suifamerazine by gastric tube (16) in doses known to produce therapeutic 
levels in mice (17).  10 mg. of sulfamerazine were administered every day at 9 a.m. and 5 p.m. 
In two instances groups of mice were bled to death at the conclusion of treatment and the levels 
of sulfameraxine were determined by a standard method (18). 
Observation of Rcsults.--The development of pneumococcal infection in the rats was deter- 
mined by daily cultures of blood taken from the tail (11) in anlmais still alive and by observa- 
tion of gross lesions and cultures of the lung and blood of the heart at autopsy.  Rats surviving 
5 to 7 days after inoculation with pneumococci were killed with ether and similar observations 
made. 
Evidence of bacterial infection in mice was obtained by mincing the left lobes of the lungs 
with scissors in a sterile Petri dish and preparing cultures of this tissue on blood agar plates. 
In all instances, the identity of pneumococci obtained in culture was confirmed by the Neufeld 
reaction with Type I  rabbit antiserum and usually the number of organisms was so great in 
mice dead or dying of pneumococcal infection that demonstration of Quellung was readily made 
in direct preparations from minced portions of the left lung.  Surviving mice were killed 14 
days after original inoculation for inspection and culture of the lung. 
For microscopic study of lesions in mice, the lungs were fixed by introducing Zenker's solu- 
tion containing 10 per cent formalin into the trachea by a cannula as in experiments with rats 
(20, 11).  Sections were stained with hematoxylin and eosin for study of the cellular reactions 
and by the Gram-Weigert method for demonstration of bacteria. 
The statistical significance of the results has been confirmed by use of a  formula for de- 
termination of the value of chi square with small numbers (19). 8 
EXPEPT~.F~-NTAL PROCEDURES  AND  RESULTS 
Sulfonam~de Chemotherapy of Pneumococcal Pneumonia  Superimposed  upon 
Viral Pneumonia  in Rats.--The  demonstration  of a  mild infection of rats with 
influenza virus  (9)  made it possible to study  combined viral and bacterial in- 
fections in this animal 
The viral infection was produced in rats by intrabronchiai inoculation with heavy suspen- 
sions of pulmonary tissue of mice infected with the PR8 strain of influenza virus as in the 
earlier experiments, and 2 days later a suspension of Type I pneumococci was given by intra- 
bronchial cannula with the same technique as that used for the virus in order to place the or- 
ganisms as nearly as possible directly on the viral lesion.  Half of the animals in each experi- 
ment were given sulfonamide chemotherapy and all were observed for the development of 
pneumococcal pneumonia and bacteremia.  In rats developing pneumococcal infection death 
resulted in all animals, usually in 2 to 3 days.  Extensive areas of dark red or gray consolida- 
tion were noted in the lungs of these rats and turbid fluid was frequently found in the pleurai 
and pericardial cavities.  Cultures of blood taken from the tail during life and from the heart 
at autopsy showed many pneumococci.  Large numbers of organisms were demonstrated at 
autopsy also in the lung and the fluid of the pleural and pericardi~ cavities. 
5 gm. of para-aminobenzoic acid were dissolved in 100 ml. cf distilled water and the solu- 
tion was neutralized v~ith sodium hydroxide.  5 ml. of this preparation were given by gastric 
tube. 
s We wish to acknowledge with thanks the advice of Dr. E. Gurney Clark concerning the 
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The results of chemotherapy are seen in Table II and show that pneumococcal 
pneumonia was successfully treated with sulfapyridine in spite of the presence 
of infection of the same portion of the lung with influenza virus.  The outcome 
of these experiments in rats seemed clear, but it was considered desirable to 
perform similar experiments in mice because of the relative mildness of the viral 
infection in rats. 
Effect  of Reinstillation  of Fluid  on Sublethal  Viral  Infection  in  Mice.rain 
planning experiments on combined viral and bacterial infection in mice, it was 
apparent that strict account would have to be taken of the phenomenon de- 
scribed  by Taylor (21)  who  showed  that  the  reinstillation  of fluid  into  the 
respiratory passages of mice suffering from a non-fatal infection with influenza 
virus would convert the process into a fatal one. 
TABLE II 
Chemotherapy of Pneumococcal Infection Superimposed upon Influenza Viral Pneumonia in 
Rats 
No. of 
experiment 
Dose of 
pneumococci 
24,000 
50,000 
900,000 
Sulfapyridine 
chemotherapy 
Continued 
Stopped* 
Continued 
Stopped* 
Treated 
Not treated 
Development  of fatal pneumococcal infection 
Positive  Negative 
0  12 
5  5 
0  7 
6  2 
0  8 
10  0 
Doubtful 
* Sulfapyridine was discontinued and para-aminobenzoic  acid given in order to stop further 
sulfonamide action. 
In order to test this observation of Taylor, mice were given sublethal doses 
of influenza virus by intrabronchial cannula and,  1  to 7 days later,  were re- 
inoculated with broth or physiological salt solution by the same method.  The 
results shown in Table III confirm the  observation concerning  the effect of 
reinocnlation of fluid on sublethal viral infection. 
Chemotherapy of Combined Infection Produced by Inoculation  of Mixtures of 
Virus and Bacteria in Mice.--The fact that an inoculation of fluid upon an ex- 
isting sublethal viral infection causes it to become fatal poses a  technical ob- 
stacle in the study of combined bacterial and viral infection in mice.  It is 
apparent that inoculation of the fluid alone of a bacterial suspension can render 
the viral infection fatal. 
In order to avoid the lethal effect of a second inoculation of fluid, suspensions 
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influenza virus and half of the mice were treated with sulfamerazine starting 6 
hours before inoculation of the infectious agents.  The outcome of these ex- 
periments is recorded in Table IV and it indicates that the combined infection 
was rapidly fatal in the controls while the treated mice survived and showed 
bacteria-free sublethal viral lesions when examined later. 
The experiments of Table IV show that the severe bacterial infection was con- 
trolled by sulfonamide chemotherapy in spite of the coexistence of a sublethal 
viral infection of the lung.  Since viral infection of this intensity did not inter- 
fere with the sulfonamide action, it became necessary to determine whether a 
severe lethal viral infection would alter the results of therapy of the  bacterial 
infection.  For this purpose, dilutions containing many lethal doses of virus 
were mixed with the suspensions of bacteria and inoculated intrabronchially. 
Sulfonamide chemotherapy was carried out as before.  In these experiments, 
TABLE III 
Consersion of a Sublethal into a Lethal In rextion zoith Influenza Virus by Reinoculation of Fluid 
Reinoculated  Not reinoculated 
No. of 
experi- 
ment 
Sublethal dose* 
dilution 
lO-~ 
0.5 X  10 -~  i 
0.5 X  I0  -T 
Tests  of 
sublethal 
dose~ 
1 
2 
3, 4 
Interval 
of reinoc- 
ulation 
days 
3 
5 
3 
Second 
inoculum 
Broth 
Broth 
Saline 
No.  re- 
inocu- 
lated 
21 
10 
21 
Survi- 
vors 
Survi- 
vors 
showing 
lesions 
No,  not 
reino- 
culated 
12 
12 
18 
Survi- 
vors 
7 
10 
18 
i Survi- 
vors 
showin~ 
lesions 
7 
10 
17 
* PR8 strain. 
Numbers of experiments in Table I. 
the results of treatment were evaluated by killing the surviving mice on the 
5th day after inoculation and making cultures of their lungs.  The results are 
presented in Table V and it is apparent that even such a severe viral infection 
did not interfere with the chemotherapeutic effect. 
Bacterial Pneumonia Superimposed upon  Viral Pneumonia by Inhalation of 
Fine Droplets.--In the preceding experiments, the chemotherapeutic effect took 
place in spite  of severe viral infection.  Nevertheless,  inflammatory lesions 
from the viral infection were found to be absent 24 hours after inoculation and 
the possibility existed  that interference with sulfonamide action on bacteria 
might depend on the existence of  the inflammatory reaction to viral infection 
during the early hours of the bacterial infections. 
In order to superimpose the bacterial infection at a  time when the lesions 
from viral infection were at  their height , it was necessary to find a way to ad- 
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ber of preliminary  experiments demonstrated that the inhalation of fine droplets 
of fluid did not cause the sublethal virus infection to become lethal.  Further- 
more, the inhalation of fine droplets of a  heat-killed suspension of pneumococci 
did not make the viral infection become fatal in fifteen of sixteen mice. 
When mice with sublethal viral infection were allowed to inhale fine droplets 
TABLE IV 
Chemotherapy of Infection  Resulting from Inoculation  of Mixtures of Bacteria and Sublethal 
Doses of Influenza  Virus in Mice 
No. of 
experi. 
ment 
Influenza virus  Bacteria  Treated  Untreated 
Strain  Sublethal 
dose 
dilution 
Weiss  2 X  10  -7 
PR8  10  -7 
Tests 
of sub- 
lethal 
dose* 
Culture 
Pneumococd 
Streptococci 
Dilu- 
;  tion of 
i  cul- 
ture 
I  i 
i10  ~ 
i 1:50 
No. 
inocu. 
lated 
9 
14 
Survi- 
vors  No. 
Survi-  show-  inocu- 
vors  ing  lated 
lesion." 
9  9~  is 
14  14~  14 
Survi. 
vors 
o§ 
l§ 
Survi. 
vors 
show- 
lng 
lesion.' 
* Numbers of  experiments in Table I. 
Cultures at autopsy showed no growth. 
§ Pneumococci or streptococd recovered from the lungs of all dead mice. 
TABLE  V 
ChonoUwrapy of Infection Resulting from Inoculation of Mixlures of Bacteria and Lethal Dose~ 
of Influenza Virus in Mice 
Influenza virus 
No. of 
experi- 
ment  Strain  Lethal 
dose 
dilutlo~ 
1  PR8  10  -6 
2  PR8  10  -1~ 
Bacteria 
Culture 
Dilu- 
tion of 
culture 
Pneumococci  10  ~ 
Streptococci  1:25 
Treated 
No.  No. with  No. 
inocu-  positive  showing 
lated  cultures  lesions 
20  0"~  18§ 
14  O*  12§ 
Untreated 
No.  No. wit| 
inocu-  positive 
lated  cultures 
18  1811 
14  1411 
* Killed for culture and observation  on the 5th day after inoculation. 
:~ Blood pooled from 8 of these mice showed a  concentration of sulfamerazine of 31.8 rag. 
per  100 ml. 
§ Two died before the 5th day and lesions could not be distinguished from post mortem 
changes. 
H Died within 72 hours. 
of a suspension  of virulent pneumococci or hemolytic streptococci  for 3 to 4 
hours, they developed secondary bacterial pneumonia and died usually 2 to 6 
days later.  In contrast, normal mice placed in the jar as controls did not de- 
velop any obvious illness and survived (22-24).  Table VI shows the results of 
experiments  demonstrating the difference in susceptibility to inhaled bacteria 
of mice with sublethal viral infection compared with normal mice. 512  SUL~ON/,~TBE CHEMOTHERAPY 
Histopathology  of Combined  Viral and Bacterial Pneumonia.--Observation  of 
pulmonary lesions induced  in mice by influenza virus alone 4  to  7 days after 
inoculation  confirmed  descriptions  recorded  in  the  literature  (25-30).  By 
this time, destruction  d  the bronchial epithelium had taken place and various 
stages d  regeneration of the mucosa could he recognized.  The lumina  of the 
bronchi were either empty or contained  large compact masses of polymorpho- 
nuclear leucocytes.  Infiltrating cells in the peritruncal areas and in the lumina 
and walls of the alveoli were almost all mononuclear and closely packed collec- 
tions  of lymphocytes  (probably lymphoid  tissue)  were more prominent  than 
normal. 
TABLE VI 
Inhalation  of Fine Droplets of Bacterial Suspension  by Normal Mice and Mice with Sublethal 
Viral Infection 
No. of  Sublethal 
experi-  dose of virus*  ment 
dilution 
1  0.5  X  10  -7 
2  0.5  X  10-  7 
3  0.5 X  10-  7 
411  m-' 
5  10  -7 
6  10-  7 
Tests  I 
of sub- I  b 
lethal [ 
dise~  b 
3,4  I 
3,4  I 
3,4  I 
rval 
teen 
~us  Species of bacteria 
xd 
eria 
ys 
Pneumococci 
Pneumococci 
Pneumococci 
Pneumococci 
Pneumococci 
Streptococci 
Sublethal viral 
infection 
Period [  ..... 
of in-  ~ lrvi. 
halationl  Nc  ~  • ]  'ors 
(  ~t  tl-  L  W  III0  ,  !  0  -  lat~  v(  ~§  ~ng 
__[__  11, flora 
hrs.  I 
2  14  8 
4  19  6 
3  15 
4  14  1 
2  19  2 
3  14  ¶ 
Normal 
No.  Survi-  vors 
14  14 
19  i8 
12  9 
15  15 
22  19 
14  13 
* PR8 strain. 
:~ Numbersof experiments in Table I. 
§ Cultures  of the lungs  of dying mice showed pneumococci  or streptococci  except for 2 
mice in experiment 2. 
[] Done as part of Experiment 1, Table VII. 
¶ Not observed. 
When mice with sublethal viral infection of this duration were allowed to in- 
hale fine droplets of bacterial culture, the lungs showed all these lesions due to 
viralinfection with the addition of infiltrations of polymorphonuclear leucocytes 
in various parts of the lung and edema fluid in some of the alveoli.  There was 
considerable variation in the distribution of these polymolphonuclear leucocytes 
since they occurred in loci in some sections and more diffusely in others.  The 
intensity  of the polymorphonuclear infiltration  varied from sections in which 
large densely packed masses of cells were present throughout to a few instances 
where they were in small enough number to be of doubtful significance.  Gram- 
Weigert stain did not reveal bacteria in these lesions during the first 24 hours C.  G.  HARlrORD,  M.  R.  SMITH,  AND W.  BARRY  WOOD, yR.  513 
after exposure to the organisms, but pneumococci were numerous in the lesions 
just before death. 
In view of the possible importance of edema fluid in the bronchi, a review of 
the sections was made in order to estimate its frequency and amount.  It was 
found that very few bronchi contained any edema fluid and that when it war 
present the amount was usually small. 
Sulfonamide Chemotherapy of Combined Viral and Bacterial Pneumonla.- 
Administration  of sulfamerazine was begun 24 hours after inhalation of the 
bacteria in order to allow the viral and bacterial lesions to coexist for as long 
time as possible.  The outcome of these experiments is shown in Table VI: 
and  it  can be seen that  treated animals  survived and revealed bacteria-fre~ 
viral lesions when examined 2 weeks later. 
TABLE VII 
Chemotherapy of Bacterial Pneumonia Superimposed upon Influenza  Viral Infection in Mics 
No.  oi 
experi- 
ment 
Strain 
f viru 
PR8 
PR8 
PR8 
Lee 
PR8 
Sub-  Tests 
lethal  'f sub 
lose  o  ~ethal 
virus  dose* 
ilutio 
10  -7  3, 4 
10  -7  3, 4 
10  -~  3  4 
lO-,  } 
10  -~  3, 4 
In~  rval 
:U- 
i~  on  o  ~s 
hal  ~rla 
Bacteria 
Pneumococci 
Pneumococci 
Pneumococci 
Pneumococci 
Streptococci 
Period 
of in- 
hala- 
tion 
~r$. 
4 
3 
3 
3 
3 
Treated  Untreated 
17[  14  [  14~[ i  [  14[  1  1 [  13 
20[  15  14[2[2017  7112 
21[19[~  I112°[s[§llS 
201 171  171 2 1 1s[414[  14 
t 15/1s  1 5 1 20/6  1  / 14 
* Numbers of experiments in Table I. 
Cultures of 2  mice showed pneumococd. 
§ Not observed. 
DISCUSSION 
The ineffectiveness of sulfonamide and sulfone chemotherapy in experimental 
influenza vilal infections is now accepted (31-35) although some early reports 
indicated  beneficial action  (36-39).  Sulfapyridine fails  to alter the  clinical 
course of uncomplicated influenza in human beings (40).  Furthermore, neither 
penicillin nor any other chemotherapeutic agent has been shown to affect this 
viral disease  (33,  34).  The  experiments reported in  this paper  confirm  the 
observation that sulfonamide chemotherapy has no effect upon the pulmonary 
lesions caused by influenza virus.  Even relatively mild, sublethal lesions in 
both rats and mice are unaffected by the drug.  In view of these facts, it is 
probable that chemotherapy will not avert fatalities when the viral infection 514  SUL¥ONAMIDE  L~  ~rOTHER.A.PY 
itself is sufficiently severe to cause death.  Although most of the clinical cases 
of uncomplicated influenza in pandemic and epidemic times are mild there is no 
way of evaluating the degree of severity of the viral infection in the fatal cases 
with simultaneous bacterial pneumonia, so the possibility remains that chemo- 
therapy will fail in such  circumstances.  Fatal cases  of influenza  have been 
reported in which bacteria were not present in the lungs  (41) or were probably 
not important (42). 
The activating effect on sublethal virus infection of the reinstillation of fluid 
suggested to Taylor (21) that secondary bacterial pneumonia in human beings 
might bring about a similar fatal viral infection.  The possibility of a poten- 
tiating effect of bacterial infection on the viral process is also suggested by the 
experiments  of Bang (43, 44)  who showed that  combined  infection of chick 
embryos with H. influenza suis and swine influenza virus resulted in a higher 
titer of virus and spread of it to portions of the embryo not reached in simple 
viral infections.  The experiments recorded in Table VII tested the hypothesis 
that the secondary bacterial pneumonia would increase the severity of the viral 
infection.  Bacterial pneumonia was allowed  to coexist with sublethal viral 
infection for 24 hours and then the bacterial component of the combined infec- 
tion was eliminated by chemotherapy.  The survival of the animals with viral 
lesions indicated that no apparent change in the degree of severity of the viral 
process resulted from the bacterial pneumonia. 
The effect of reinstilled fluid in mice suggests  that the presence of fluid in the 
bronchi may be of more importance in determining the  severity of the viral 
infection than the bacterial pneumonia per se.  There appears to be no reason 
why endogenous fluid in the bronchi such as edema fluid in pneumococcal pneu- 
monia (11, 45, 46)  or pulmonary edema from any cause would not have the 
same effect as exogenous instillation of fluid.  This concept would explain the 
failure of secondary bacterial infection to intensify the sublethal viral infection 
in the present experiments since study of sections of lungs of such mice showed 
that the bacterial pneumonia consisted chiefly of infiltrations of polymorpho- 
nuclear leucocytes, and that edema fluid was only rarely found in the bronchi. 
The initial chemotherapeutic experiments  here reported were done on com- 
bined infection in rats, and the virus failed to interfere with the suifonamide 
effect on the bacterial infection.  This finding suggested the possibility  that 
the viral infection in the rat was not of sufficient severity to block the sulfona- 
mide action; similar experiments, therefore, were carried out with mice.  In this 
more susceptible  animal, Taylor (21) has demonstrated that a  tremendous 
multiplication of virus takes place in the first 24 hours.  In spite of this fact, 
when sublethal and lethal doses of virus were mixed with fatal but curable 
doses of bacteria sulfonamide chemotherapy was found to be effective against 
the bacterial element of the combined infection.  It must be concluded, there- 
fore, that sulfonamide drugs exert their antibacterial action even in the pres- 
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Clinical experience  (47) has shown that sulfonamide  chemotherapy is not 
effective in the treatment of purulent foci and there is experimental evidence 
(48) indicating that this failure is at least partly due to the presence  in pus of 
sulfonamide-inhibiting  substances.  By analogy it might be assumed that the 
pulmonary exudate called forth by the influenza virus would interfere with 
sulfonamide action.  This possibility was tested in experiments in which bac- 
terial infection was superimposed  upon the inflammatory lesion produced by 
influenza virus but the viral lesion was found to have no effect on the results 
of chemotherapy. 
Clinical observations  during the pandemic (4) and studies on experimental 
infections  in several  species of animals (49-57, 43, 44)  indicate increased  se- 
verity of bacterial infection of the lung when combined  with influenza viral 
infection.  The experiments  recorded in Table VI confirm this fact and have 
made it possible to deter~nine whether the potentiating effect of the viru¢ on 
the bacterial infection will interfere with chemotherapy.  The results recorded 
in Table VII indicate no interference  under such circumstances  and are con- 
sistent with clinical experience in that pneumonia following influenza  (58-60, 
8),  9  measles (61, 62), and dog distemper (63) all appear to respond  to sulfona- 
mide drugs. 
A possible explanation may be suggested  for the fact that influenza viral 
infection of the lung apparently does not interfere with the chemotherapy of 
concomitant bacterial pneumonia.  There  is  considerable  experimental evi- 
dence that the virus acts on the mucosa of the respiratory tract, thereby making 
the host susceptible to secondary pulmonary infection.  One of the chief mech- 
anisms by which the bronchi rid themselves of inhaled foreign particles is by the 
adherence  of the particles to the mucous covering of the epithelium and their 
propulsion  toward the pharynx  by ciliary action (64).  At the same time a 
characteristic feature of influenza viral infection in man (4, 65) and most other 
animals (25-30, 66, 67) is the destruction of the epithelial  cells that bear the 
cilia.  The effect of the virus on respiratory epithelium may be its main action 
in lowering resistance to bacterial infection (5, 68).  On the other hand, there 
is no evidence that influenza virus interferes with the activity of the phagocytic 
cells in the pneumonic exudate.  Studies  on the mechanism of recovery in 
bacterial pneumonia treated with chemotherapy have shown that most of the 
bacteria are ultimately destroyed by the phagocytes in the alveoli and bronchi 
(10, 69).  It is not surprising,  therefore,  that influenza infection renders  the 
host more susceptible  to bacterial infection of the lung but at the same time 
fails to interfere with the action of chemotherapy upon the secondary bacterial 
pneumonia. 
9 Meikeljohn and Eaton have observed six cases of bacterial pneumonia following Type A 
influenza.  The type of influenza was demonstrated by increase in antibodies in all cases and 
isolation of virus in five.  The secondary pneumonia responded to therapy with sulfadiazine 
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SUMMARY  AND  CONCLUSIONS 
1.  Sulfonamide chemotherapy controls the bacterial component of combined 
infection with influenza virus and pneumococci in rats. 
2.  Reinstillation of fluid  (broth, physiological salt solution) into the respira- 
tory passages of mice several days after sublethal viral infection converts the 
viral infection into a  lethal one. 
3.  Sulfonamide chemotherapy controls the bacterial component of combined 
bacterial and viral infection of mice, produced by intrabronchial inoculation of 
mixtures of bacteria and sublethal or lethal doses of virus. 
4.  Bacterial pneumonia may be superimposed upon sublethal viral infection 
in mice by inhalation of fine droplets of bacterial suspension several days after 
inoculation of virus.  Normal mice inhaling fine droplets of bacterial suspen- 
sion fail to develop obvious disease. 
5.  Sulfonamide ¢JlemotheIapy controls bacterial pneumonia superimposed on 
sublethal viral infection by inhalation of fine droplets of bacterial culture. 
6.  The secondary bacterial penumonia does not convert the sublethal viral 
infection into a lethal one. 
7.  If another pandemic of influenza occurs, it is probable that sulfonamide 
chemotherapy will be valuable in the treatment of secondary bacterial pneu- 
monia and will be effective in lowering the case fatality rate if the viral compo- 
nent of the infection is not severe enough by itself to cause death. 
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